These NRs were not differentially expressed in ERα/PGR/HER2 subgroups, with the exception of RARγ whose expression appeared to be lower in HER2-positive than in HER2-negative tumours, although statistical significance for association with HER2 status was not reached (p = 0.076). The gene discussed is ESR1; the disease is neoplasm.